Scancell Limited
Records under this name other than the patents Scancell Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 6 of 6 · Back to Scancell Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,187,600 | Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses Formerly held Term ended Term ended Jan 28, 2022 · From the USPTO record | Term ended | Term ended Jan 28, 2022 | From the USPTO record |
| US 8,273,349 | Binding member which binds to both lewis-Y and lewis-B haptens, and its use for treating cancer Formerly held Lapsed on the fee record Ended Sep 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 25, 2020 | From the USPTO record |
| US 7,267,821 | Binding member which binds to both Lewisy and Lewisb haptens, and its use for treating cancer Formerly held Lapsed on the fee record Ended Sep 11, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 11, 2019 | From the USPTO record |
| US 7,915,387 | Monoclonal antibody Sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent Formerly held Lapsed on the fee record Ended Mar 29, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2019 | From the USPTO record |
| US 7,879,983 | Binding member which binds to both Lewis-y and Lewis-b haptens, and its use for treating cancer Formerly held Lapsed on the fee record Ended Feb 1, 2019 · From the USPTO record | Lapsed on the fee record | Ended Feb 1, 2019 | From the USPTO record |
| US 6,258,528 | Signal amplification method Lapsed on the fee record Ended Jul 10, 2005 · From the USPTO record | Lapsed on the fee record | Ended Jul 10, 2005 | From the USPTO record |